CN108653434A - A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome - Google Patents
A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome Download PDFInfo
- Publication number
- CN108653434A CN108653434A CN201810754444.2A CN201810754444A CN108653434A CN 108653434 A CN108653434 A CN 108653434A CN 201810754444 A CN201810754444 A CN 201810754444A CN 108653434 A CN108653434 A CN 108653434A
- Authority
- CN
- China
- Prior art keywords
- leventhal syndrome
- pharmaceutical composition
- radix
- stein
- sputum type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000000952 spleen Anatomy 0.000 title claims abstract description 54
- 201000010065 polycystic ovary syndrome Diseases 0.000 title claims abstract description 43
- 206010036049 Polycystic ovaries Diseases 0.000 title claims abstract description 41
- 206010036790 Productive cough Diseases 0.000 title claims abstract description 41
- 208000024794 sputum Diseases 0.000 title claims abstract description 40
- 210000003802 sputum Anatomy 0.000 title claims abstract description 40
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 235000019441 ethanol Nutrition 0.000 claims abstract description 23
- 239000009636 Huang Qi Substances 0.000 claims abstract description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 claims abstract description 19
- 208000026435 phlegm Diseases 0.000 claims abstract description 19
- 230000007812 deficiency Effects 0.000 claims abstract description 16
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 241001619444 Wolfiporia cocos Species 0.000 claims abstract 4
- 239000000243 solution Substances 0.000 claims description 25
- 239000003814 drug Substances 0.000 claims description 24
- 239000012528 membrane Substances 0.000 claims description 15
- 238000000108 ultra-filtration Methods 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 7
- 229910052770 Uranium Inorganic materials 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000000469 ethanolic extract Substances 0.000 claims description 6
- 229920002521 macromolecule Polymers 0.000 claims description 6
- JFALSRSLKYAFGM-UHFFFAOYSA-N uranium(0) Chemical compound [U] JFALSRSLKYAFGM-UHFFFAOYSA-N 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 4
- 230000000857 drug effect Effects 0.000 claims description 3
- 239000012634 fragment Substances 0.000 claims description 3
- 238000013327 media filtration Methods 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 239000013049 sediment Substances 0.000 claims description 3
- 229910001220 stainless steel Inorganic materials 0.000 claims description 3
- 239000010935 stainless steel Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims 4
- 238000009505 enteric coating Methods 0.000 claims 1
- 239000002702 enteric coating Substances 0.000 claims 1
- 239000007888 film coating Substances 0.000 claims 1
- 238000009501 film coating Methods 0.000 claims 1
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 8
- 206010027339 Menstruation irregular Diseases 0.000 abstract description 8
- 208000024891 symptom Diseases 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 244000197580 Poria cocos Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 6
- 241000756943 Codonopsis Species 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 231100000397 ulcer Toxicity 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 244000303040 Glycyrrhiza glabra Species 0.000 description 4
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 4
- 235000017443 Hedysarum boreale Nutrition 0.000 description 4
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 4
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000002124 endocrine Effects 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical group O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- 229930194248 Licoflavone Natural products 0.000 description 2
- MEHHCBRCXIDGKZ-UHFFFAOYSA-N Licoflavone C Natural products CC(C)=CCC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=C(O)C=C1 MEHHCBRCXIDGKZ-UHFFFAOYSA-N 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- GKIRPKYJQBWNGO-OCEACIFDSA-N clomifene Chemical compound C1=CC(OCCN(CC)CC)=CC=C1C(\C=1C=CC=CC=1)=C(\Cl)C1=CC=CC=C1 GKIRPKYJQBWNGO-OCEACIFDSA-N 0.000 description 2
- 229960003608 clomifene Drugs 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000002662 enteric coated tablet Substances 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 239000007941 film coated tablet Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000010066 hyperandrogenism Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 229940100688 oral solution Drugs 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000016087 ovulation Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 235000021251 pulses Nutrition 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241000283966 Pholidota <mammal> Species 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000006688 Telosma cordata Species 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- -1 oral solution Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- 239000008945 zhigancao decoction Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to spleen emptiness and wet sputum type Stein-Leventhal syndrome treatment technology fields, disclose a kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome.It is made of Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and Radix Glycyrrhizae 1.5g.When making, Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and Radix Glycyrrhizae 1.5g are taken, after cleaning, water is added to be decocted, after decoction, collects the extracting solution decocted out；It then repeats to decoct, is repeatedly purified, after all material purifies, last extracting solution is mixed, ethyl alcohol is then added and is preserved.The present invention is directed to the spleen deficiency damp phlegm of Stein-Leventhal syndrome respectively, irregular menstruation symptom carries out herbal treatment, and the comprehensive symptom to patient is treated, and solves the chief complaint of spleen emptiness and wet sputum type Stein-Leventhal syndrome well.
Description
Technical field
The invention belongs to spleen emptiness and wet sputum type Stein-Leventhal syndrome treatment technology field more particularly to a kind for the treatment of spleen deficiency phlegm
The pharmaceutical composition of wet type Stein-Leventhal syndrome.
Background technology
Stein-Leventhal syndrome is a kind of endocrine for the cause of disease diversity, clinical manifestation polymorphism that Female in child bearing period is common
Metabolic disorder disease, characterized by irregular menstruation or amenorrhoea, hyperandrogenism and ovary change in more capsule samples.It is clinical
Middle spleen emptiness and wet sputum type Stein-Leventhal syndrome is more common, and Symptoms are irregular menstruation, body obesity, amenorrhoea, infertile, simultaneous
See abdominal fullness and distention；Chest tightness and emesis；Complexion is shaken white；Profuse leukorrhea；Pale tongue is fat, and tongue is greasy in vain, deep thready pulse or the spleen deficiency phlegm wet such as sliding of sinking
Symptom.Stein-Leventhal syndrome shows as irregular menstruation, obesity, crinosity, acne the puberty more, in child-bearing period mainly for not
Pregnant and metabolic syndrome is mostly angiocardiopathy complication etc. in climacteric, which annoyings all one's life of patient, and along with
Serious psychiatric problem.Stein-Leventhal syndrome is the hot and difficult issue studied both at home and abroad, and doctor trained in Western medicine mostly uses to the ill at present
Treatment uses clomiphene as a line promoting ovulation drug for infertile；It is controlled using once quick dose of insulin for insulin resistance
It treats；For hyperandrogenism using the male treatment of drop.But current research discovery some patientss are there are clomiphene resistance or not
Sensitivity phenomenon cannot achieve the effect that ovulation induction after patient medication, and Western medicine side effect is big.Between these, the present invention proposes one
Kind treats the pharmaceutical composition of spleen emptiness and wet sputum type Stein-Leventhal syndrome, is adjusted from " Overall View " to patient.
In conclusion problem of the existing technology is：Western medicine is symptomatic treatment, can not be from entirety to patient's
Symptom is intervened comprehensively, and Western medicine toxic side effect is big, becomes pregnant after medication, and the Long-Term Safety of female youngster makes people worried.
Solve the difficulty and meaning of above-mentioned technical problem：
Invention content
In view of the problems of the existing technology, the present invention provides a kind of spleen emptiness and wet sputum type Stein-Leventhal syndromes for the treatment of
Pharmaceutical composition.
The invention is realized in this way a kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome, described
Treat spleen emptiness and wet sputum type Stein-Leventhal syndrome pharmaceutical composition by Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g,
Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and Radix Glycyrrhizae 1.5g compositions.
Another object of the present invention is to provide a kind of medicine groups of the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
The preparation method of object is closed, the preparation method of the pharmaceutical composition of the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome includes following
Step：
Step 1, make when, take Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and
Radix Glycyrrhizae 1.5g adds water to be decocted after cleaning, and after decoction, collects the extracting solution decocted out；
Step 2, then repeat decoct, repeatedly purified, all material purification after, by last extracting solution into
Row mixing is then added ethyl alcohol and is preserved.
Further, in the step 1 by extracting solution by filtering accuracy be 0.08 μm of media filtration, to remove extracting solution
Grain size in III is more than 0.08 μm of macromolecular substances, then filter liquor is filtered out in extracting solution by ultra-filtration filters without drug effect
Molecular weight be more than 5000~10000 dalton organic macromolecule material, obtain the high effective components of Chinese medicinal extracting solution of purity；
Ultra-filtration filters, used ultrafiltration membrane select molecular weight cut off for 5000~10000 dalton with processing Chinese medicine difference；It is described super
Filtration filter, can choose the ultrafiltration membrane of different molecular weight cut offs according to the molecular weight of extracted effective components of Chinese medicinal；
Further, effective components of Chinese medicinal is further purified, is concentrated in the step 1：By extracting solution by NF membrane to go
Except the organic solvent of the aqueous solutions of organic solvent in extracting solution IV；The uranium filtration filter, used uranium filter membrane is with organic molten
The difference of organic solvent molecule amount selects molecular weight cut off for the NF membrane of 200~500 dalton in agent aqueous solution.
Further, Radix Astragali entity is broken in the step 1 and spits into 0.5~1 centimetre of big fragment, put into the extraction of stainless steel
In pot, add 95% edible ethanol of 8 times of Radix Astragali dry weight, 78 DEG C are flowed back 1 hour, and alcohol extract is released；Residue remains in pot, then adds
75% edible ethanol of 8 times of weight, 78 DEG C are flowed back 1 hour, and ethanol extract is released；Residue remains in pot, then adds 8 times of amounts
50% edible ethanol, 78 DEG C are flowed back 1 hour, and ethanol extract is released；3 alcohol extracts are merged, it is small that 10 are stood in hopper
When, supernatant liquor is taken out, bottom sediment is discarded；Supernatant recycles ethyl alcohol.
Another object of the present invention is to provide a kind of drugs by the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Tablet prepared by composition.
Another object of the present invention is to provide a kind of drugs by the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Film coated tablet prepared by composition.
Another object of the present invention is to provide a kind of drugs by the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Enteric coated tablet prepared by composition.
Another object of the present invention is to provide a kind of drugs by the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Capsule prepared by composition.
Another object of the present invention is to provide a kind of drugs by the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Oral solution prepared by composition.
Advantages of the present invention and good effect are：The pharmaceutical composition of this treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome
Ingredient is divided into three categories, and is directed to spleen deficiency respectively, damp phlegm and irregular menstruation symptom carry out invigorating spleen to remove dampness, coordinating Chong and Conception Vessels, for more
The common sympton of capsule Ovary Syndrome carries out wholistic therapy to patient, solves spleen emptiness and wet sputum type Stein-Leventhal syndrome well
Chief complaint.This medicine composition components is clear, and compatibility is reasonable, and ingredient is Chinese medicine, based on invigorating the spleen, and with
Dampness removing resolving sputum is finally reached coordinating Chong and Conception Vessels, and the menstruation rhythm and pace of moving things is orderly, and spleen is strong, and water is wet is able to transporting, to metabolic problems such as obesities
It is improved well, solves the problems, such as endocrine metabolism to the greatest extent for patient.
Kidney and spleen invigorating, the resolving sputum dampness removing ingredient of the present invention：Radix Astragali, Radix Salviae Miltiorrhizae, Poria cocos, dried orange peel, rhizoma atractylodis；Adjust menstruation, conditioning
Ingredient is appointed in punching：Radix Angelicae Sinensis, Rhizoma Chuanxiong, Radix Glycyrrhizae；Radix Astragali, Radix Salviae Miltiorrhizae kidney and spleen invigorating qi-regulating in side, Poria cocos, dried orange peel, rhizoma atractylodis resolving phlegm and drying damp invigorating the spleen,
Radix Angelicae Sinensis, Rhizoma Chuanxiong invigorate blood circulation, coordinating Chong and Conception Vessels, Radix Glycyrrhizae coordinating the drug actions of a prescription.Though it is trouble, assertive evidence that this disease spleen emptiness and wet sputum type PCOS, which is phlegm wet,
Belong to actual situation, mostly by spleen deficiency anemia, then involve kidney yang long, or form for stagnation of liver qi, the transporting of spleen is powerless, wet to be polymerized to phlegm.
Its therapy should be that principle is used cooperatively using the method for logical benefit with " treatinging deficiency with tonification, sthenia syndrome requiring purgation ", and tradeoff then weighs.The present invention is by grey
It is attached lead phlegm ball (《YE Tian shi female section pandect》Change and cuts out.
Description of the drawings
Fig. 1 is the preparation of the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome provided in an embodiment of the present invention
Method flow diagram.
Specific implementation mode
In order to further understand the content, features and effects of the present invention, the following examples are hereby given, and coordinate attached drawing
1 detailed description are as follows.
The structure of the present invention is explained in detail below in conjunction with the accompanying drawings.
The pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome provided in an embodiment of the present invention is by Radix Astragali 2g, pellet
Join 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and Radix Glycyrrhizae 1.5g compositions.
As shown in Figure 1, the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome provided in an embodiment of the present invention
Preparation method include the following steps：
S101：When making, Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and sweet are taken
Careless 1.5g adds water to be decocted after cleaning, and after decoction, collects the extracting solution decocted out；
S102：It then repeats to decoct, repeatedly be purified, after all material purifies, last extracting solution is carried out
Mixing is then added ethyl alcohol and is preserved.
In step S101 by extracting solution by filtering accuracy be 0.08 μm of media filtration, to remove in extracting solution III
Grain size is more than 0.08 μm of macromolecular substances, then filter liquor is filtered out the molecular weight without drug effect in extracting solution by ultra-filtration filters
More than the organic macromolecule material of 5000~10000 dalton, the high effective components of Chinese medicinal extracting solution of purity is obtained；Ultra filtration
Filter, used ultrafiltration membrane select molecular weight cut off for 5000~10000 dalton with processing Chinese medicine difference；The ultra filtration
Filter, can choose the ultrafiltration membrane of different molecular weight cut offs according to the molecular weight of extracted effective components of Chinese medicinal；
Effective components of Chinese medicinal is further purified, is concentrated：Extracting solution is removed by NF membrane organic in extracting solution IV
The organic solvent of solvent aqueous solution, to achieve the purpose that purification, concentration；The described uranium filtration filter, used uranium filter membrane is with having
The difference of organic solvent molecule amount selects molecular weight cut off for the NF membrane of 200~500 dalton in solvent aqueous solution.
Radix Astragali entity is broken and spits into 0.5~1 centimetre of big fragment, puts into the extraction pot of stainless steel, adds 8 times of Radix Astragali dry weight
95% edible ethanol, 78 DEG C are flowed back 1 hour, and alcohol extract is released.Residue remains in pot, then adds 75% edible second of 8 times of weight
Alcohol, 78 DEG C are flowed back 1 hour, and ethanol extract is released.Residue remains in pot, then adds 8 times of 50% edible ethanols of amount, 78 DEG C of reflux
1 hour, release ethanol extract.3 alcohol extracts are merged, 10 hours are stood in hopper, supernatant liquor is taken out, discards bottom
Portion's sediment；Supernatant recycles ethyl alcohol.The concentrate gone after ethyl alcohol can be made into raised path between farm fields agent, and plastic is done after also can drying or be spray-dried
The preparations such as capsule.
It is provided in an embodiment of the present invention treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome pharmaceutical composition can be tablet,
Film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral solution, granule, honey pill agent, powder, pellet
Agent, solution etc..
The application principle of the present invention is further described with reference to pharmacological analysis.
Radix Astragali, exterior deficiency spontaneous perspiration：It is chiefly used in the weak caused spontaneous perspiration of physically weak table.Such as exterior Qi instability, and sweating, with Radix Astragali with white
Art, it is windproof control it, long term usage must imitate.Side such as Yupingfeng San；Also it can match Fructus Tritici Levis, radix ephedrae etc..Night sweat due to yin deficiency：It can be with Radix Rehmanniae, wheat
The drugs for nourishing yin such as winter are the same as use.Acute nephritis edema：For the void oedema caused by YANG QI deficiency, and often with tetrandra root, Poria cocos, Rhizoma Atractylodis Macrocephalae etc.
It closes and uses, side such as Tetrandra and Astragalus Decoction.Oedema due to chronic nephritis, spleen kidney deficiency：Often with Radix Codonopsis, Rhizoma Atractylodis Macrocephalae, Poria cocos with use.Yang-energy is weak：With
It invaginates in sore not diabrosis long, has and promote diabrosis and limitation effect.Ulcer not penetrator long, often with pangolin, spina gleditsiae, when
Return, Rhizoma Chuanxiong is the same as use.Sore diabrosis：It does not close up long, there is the effect of promoting granulation and wound healing, often match honeysuckle flower, spina gleditsiae, Chinese violet etc..Fester cleans,
It is equal with Radix Codonopsis, Chinese cassia tree and uses.Syndrome of deficiency of lung qi：With the passing of time, shortness of breath and tired spirit, phlegm harmony is powerlessly brought up cough and asthma in lung.Chang Peiwu asters, coltsfoot
Deng, warm lung Dingchuan, the product of strong lung qi.Spleen gives birth to phlegm, and lung stores up phlegm, so strong lunar with eliminating the phlegm, Radix Astragali tonifying Qi is so outstanding be apt to control the deficiency of vital energy.
The deficiency of vital energy is weak：Lassitude hypodynamia or the sinking of qi of middle-jiao, rectal prolapse, the prolapse of uterus.Air making-up and spleen enlivening, often with the compatibilities such as Radix Codonopsis, Rhizoma Atractylodis Macrocephalae；For
Benefiting qi and raising yang and lift sunken, often shared with Radix Codonopsis, cimicifugae foetidae, radix bupleuri, honey-fried licorice root etc..
Radix Salviae Miltiorrhizae is used for chest impediment and cardialgia, gastral cavity abdomen hypochondriac pain, the accumulation of lump in the abdomen lump in the abdomen, hot numbness pain, dysphoria and insomnia, irregular menstruation, dysmenorrhoea warp
It closes, sore swell and ache curative.
Poria cocos is used for oedema oliguria, phlegm retention anti-dazzle nervous, spleen eating less, loose stool diarrhea, confused and worried, insomnia of palpitating with fear.
Dried orange peel is used for abdominal fullness and distention, and deficiency of food is vomited and diarrhoea, coughing with a lot of sputum.
Rhizoma atractylodis are used for damp retention in middle-jiao, and abdominal fullness and distention, diarrhea, oedema, tinea pedis impotence is preesed, arthralgia pain due to rheumatism, anemofrigid cold, yctalopia,
Eyes dusk is puckery.
Radix Angelicae Sinensis is enriched blood；Promoting blood circulation；Menstruction regulating and pain relieving；Moisturize laxation.The main all cards of the deficiency of blood；Irregular menstruation；Amenorrhea；Dysmenorrhoea；Abdominal mass knot
It is poly-；Uterine bleeding；Asthenia cold abdominalgia；Impotence numbness；Numbness；Intestines are dry and shit is difficult；Weight after dysentery characterized by blood in the stool；Ulcer sores；Injury from falling down.
Rhizoma Chuanxiong, promote breath and open depression, method wind-dryness is wet, promoting blood circulation and stopping pain.It is dizzy to control air-cooled headache rotation, hypochondriac pain abdomen pain, arthritis muscle contraction, warp
It closes, has difficult labour, postpartum stasis block pain, ulcer sores.For irregular menstruation, closed dysmenorrhea, lump in the abdomen abdominal pain, chest side of body shouting pain, tumbling and swelling,
Headache, arthralgia pain due to rheumatism.
Radix Glycyrrhizae is used for the heart qi deficiency, palpitation and severe palpitation, intermittent pulse and deficiency of spleen-QI and stomach-QI, lassitude hypodynamia etc..The former, often and cassia twig
Compatibility, such as Ramuli Cinnamomi and Glycyrrhizae Decoction, zhigancao decoction.The latter is often equal with Radix Codonopsis, Rhizoma Atractylodis Macrocephalae and uses, such as ball in Sijunzi Tang, reason.For
Ulcer sores, abscess of throat etc..It can be applied alone, for oral administration or external application or compatibility application.Ulcer sores are often equal with honeysuckle, Fructus Forsythiae
With playing clearing heat and detoxicating work(, such as Xian fang Huoming Yin altogether.Abscess of throat, often with campanulaceae with use, such as Radix Platycodonis decoction.If in pesticide, food
Poison often matches mung bean or is decocted in water for oral dose with windproof.For asthma and cough.It can be applied alone, it also can compatibility other drugs application.Such as control damp phlegm cough
The erchen tang coughed；Control the Linggan Wuwei Jiangxin Tang of cold productive cough asthma；Control the sangxing decoction of dry stool phlegm cough；It controls heat toxin and causes lung carbuncle cough saliva raw meat
The Radix Platycodonis decoction of smelly phlegm；Control the Gancao Ganjiang soup etc. of cough saliva foam.Another cough due to wind-heat evil, cough due to wind-cold evil, phlegm heat cough also Chang Peiwu
Using.For having a stomachache, abdominal pain and gastrocnemius contraction urgency pain etc.；For reconciling the strong of some drugs.Such as season CHENGQI TANG originally
Product mitigate rheum officinale, the discharge function of saltcake and its stimulation to gastrointestinal tract.In addition, it is all also to commonly use this product reconciliation in many prescriptions
Medicine.Radix Glycyrrhizae has similar adrenocortical hormones fuction.There is inhibiting effect to gastroxia caused by histamine；And have antiacid
It is acted on gastrointestinal smooth muscle spasm is alleviated.Licoflavone, extract of licorice root and enoxolone have apparent antitussive effect；Eliminating the phlegm is made
With also more significant, action intensity is glycyrrhizic acid>Licoflavone>Extract of licorice root.Radix Glycyrrhizae is also anti-inflammatory, anti-allergic effects, can protect
The throat and tunica mucosa tracheae for inflammation of taking care of hair.Extract of licorice root has certain poisonous substances with glycyrrhizic acid the detoxication of similar glucuronic acid.
Radix Glycyrrhizae was commonly used to treat with climacteric and the symptom that comes in Radix Glycyrrhizae because contain glycyrrhizin, was a kind of compound of similar hormone,
It helps to balance the hormone-content in women body.Hypo acid contained by Radix Glycyrrhizae can block the effect of Induced by Carcinogen tumour growth.
For the present invention during clinical observation, 102 patients complete clinical observation, and case is exited without falling off.By this
The spleen emptiness and wet sputum type PCOS patient of three courses for the treatment of of invention drug therapy, reference《New Chinese medicine guideline of clinical investigations》Judgement mark
Standard, treatment case 51, effective 33, effective 16, invalid 2, obvious effective rate 64.7%, total effective rate 96.1%, observation group
Clinical effectiveness is more notable in terms of obvious effective rate and total effective rate；After treatment, patient T, LH, FSH serum endocrine are horizontal
There are decline, pretherapy and post-treatment LH/FSH, T value more to have extremely significant difference (P ＜ 0.01).
The above is only the preferred embodiments of the present invention, and is not intended to limit the present invention in any form,
Every any simple modification made to the above embodiment according to the technical essence of the invention, equivalent variations and modification, belong to
In the range of technical solution of the present invention.
Claims (10)
1. a kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome, which is characterized in that the treatment spleen deficiency phlegm
The pharmaceutical composition of wet type Stein-Leventhal syndrome is by Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, river
Rhizome of chuanxiong 1g and Radix Glycyrrhizae 1.5g compositions.
2. a kind of preparation method of the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome as described in claim 1,
It is characterized in that, the preparation method of the pharmaceutical composition of the treatment spleen emptiness and wet sputum type Stein-Leventhal syndrome includes following step
Suddenly：
Step 1 takes Radix Astragali 2g, Radix Salviae Miltiorrhizae 3g, Poria cocos 2g, dried orange peel 2g, rhizoma atractylodis 4g, Radix Angelicae Sinensis 3g, Rhizoma Chuanxiong 1g and Radix Glycyrrhizae when making
1.5g adds water to be decocted after cleaning, and after decoction, collects the extracting solution decocted out；
Step 2 then repeats to decoct, is repeatedly purified, after all material purifies, last extracting solution is mixed
It closes, ethyl alcohol is then added and is preserved.
3. the preparation method of the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome as claimed in claim 2,
Be characterized in that, in the step 1 by extracting solution by filtering accuracy be 0.08 μm of media filtration, to remove in extracting solution III
Grain size is more than 0.08 μm of macromolecular substances, then filter liquor is filtered out the molecular weight without drug effect in extracting solution by ultra-filtration filters
More than the organic macromolecule material of 5000~10000 dalton, the high effective components of Chinese medicinal extracting solution of purity is obtained；Ultra filtration
Filter, used ultrafiltration membrane select molecular weight cut off for 5000~10000 dalton with processing Chinese medicine difference；The ultra filtration
Filter, can choose the ultrafiltration membrane of different molecular weight cut offs according to the molecular weight of extracted effective components of Chinese medicinal.
4. the preparation method of the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome as claimed in claim 2,
It is characterized in that, effective components of Chinese medicinal is further purified, concentrated in the step 1：By extracting solution by NF membrane to remove extraction
The organic solvent of aqueous solutions of organic solvent in liquid IV；The uranium filtration filter, used uranium filter membrane are water-soluble with organic solvent
The difference of organic solvent molecule amount selects molecular weight cut off for the NF membrane of 200~500 dalton in liquid.
5. the preparation method of the pharmaceutical composition for the treatment of spleen emptiness and wet sputum type Stein-Leventhal syndrome as claimed in claim 2,
It is characterized in that, Radix Astragali entity is broken in the step 1 and spits into 0.5~1 centimetre of big fragment, puts into the extraction pot of stainless steel, adds
95% edible ethanol of 8 times of Radix Astragali dry weight, 78 DEG C are flowed back 1 hour, and alcohol extract is released；Residue remains in pot, then adds 8 times of weight
75% edible ethanol, 78 DEG C flow back 1 hour, release ethanol extract；Residue remains in pot, then adds 8 times of amounts 50% edible
Ethyl alcohol, 78 DEG C are flowed back 1 hour, and ethanol extract is released；3 alcohol extracts are merged, 10 hours are stood in hopper, in taking-up
Layer clear liquid, discards bottom sediment；Supernatant recycles ethyl alcohol.
6. a kind of tablet prepared by the pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome described in claim 1.
7. a kind of film-coating prepared by the pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome described in claim 1
Tablet.
8. a kind of enteric coating prepared by the pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome described in claim 1
Tablet.
9. a kind of capsule prepared by the pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome described in claim 1
Agent.
10. a kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome described in claim 1 is prepared oral
Liquid.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810754444.2A CN108653434A (en) | 2018-07-11 | 2018-07-11 | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810754444.2A CN108653434A (en) | 2018-07-11 | 2018-07-11 | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108653434A true CN108653434A (en) | 2018-10-16 |
Family
ID=63772613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810754444.2A Pending CN108653434A (en) | 2018-07-11 | 2018-07-11 | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108653434A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109224054A (en) * | 2018-11-28 | 2019-01-18 | 辽宁中医药大学 | A kind of Chinese medicine composition and preparation method thereof for endomorphy type PCOS point-application |
| CN111317777A (en) * | 2020-05-08 | 2020-06-23 | 河南中医药大学 | Traditional Chinese medicine decoction for treating kidney deficiency and phlegm dampness type polycystic ovarian syndrome infertility |
| CN116036162A (en) * | 2023-01-17 | 2023-05-02 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and application thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145041A (en) * | 2010-02-09 | 2011-08-10 | 侯凤祥 | Pharmaceutical composition with function of treating polycystic ovary syndrome |
| CN104147551A (en) * | 2014-09-02 | 2014-11-19 | 马俊安 | Traditional Chinese medicine for treating polycystic ovarian syndrome |
| CN105596495A (en) * | 2016-01-06 | 2016-05-25 | 侯丽辉 | Chinese herbal compound for treating pubertal polycystic ovary syndrome |
-
2018
- 2018-07-11 CN CN201810754444.2A patent/CN108653434A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145041A (en) * | 2010-02-09 | 2011-08-10 | 侯凤祥 | Pharmaceutical composition with function of treating polycystic ovary syndrome |
| CN104147551A (en) * | 2014-09-02 | 2014-11-19 | 马俊安 | Traditional Chinese medicine for treating polycystic ovarian syndrome |
| CN105596495A (en) * | 2016-01-06 | 2016-05-25 | 侯丽辉 | Chinese herbal compound for treating pubertal polycystic ovary syndrome |
Non-Patent Citations (4)
| Title |
|---|
| 何红: "帅焘老师治疗多囊卵巢综合症的临证经验", 《云南中医中药杂志》 * |
| 宋诗思；等: "浅析治疗多囊卵巢综合征治疗经验", 《大众科技》 * |
| 崔红花;等: "正交试验优化黄芪的乙醇提取工艺", 《中草药》 * |
| 王晨晔；等: "苍附导痰汤加减联合针刺对肥胖型多囊卵巢综合征患者糖脂代谢及排卵率的影响", 《现代中西医结合杂志》 * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109224054A (en) * | 2018-11-28 | 2019-01-18 | 辽宁中医药大学 | A kind of Chinese medicine composition and preparation method thereof for endomorphy type PCOS point-application |
| CN109224054B (en) * | 2018-11-28 | 2021-08-13 | 辽宁中医药大学 | Traditional Chinese medicine composition for acupoint application of obese PCOS and preparation method thereof |
| CN111317777A (en) * | 2020-05-08 | 2020-06-23 | 河南中医药大学 | Traditional Chinese medicine decoction for treating kidney deficiency and phlegm dampness type polycystic ovarian syndrome infertility |
| CN116036162A (en) * | 2023-01-17 | 2023-05-02 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and application thereof |
| CN116036162B (en) * | 2023-01-17 | 2023-11-21 | 上海中医药大学附属岳阳中西医结合医院 | Traditional Chinese medicine composition for treating polycystic ovarian syndrome and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1330347C (en) | Gongbu ointment | |
| CN101422579B (en) | Traditional Chinese medicine preparation for treating oral ulcer | |
| CN108653434A (en) | A kind of pharmaceutical composition for treating spleen emptiness and wet sputum type Stein-Leventhal syndrome | |
| CN104306766B (en) | Prevent and treat Chinese medicinal formulae of patients with radioactive mucositis of oral cavity and preparation method thereof | |
| CN1048175C (en) | Oral liquid for regulating women's sexual function | |
| CN103330826A (en) | Traditional Chinese medicine composition for treating deficiency of lung yin | |
| CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN104940596A (en) | Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof | |
| CN105055841A (en) | Medicine for treating chronic pharyngitis and preparing method thereof | |
| CN104887747A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and preparation method therefor | |
| CN104353029A (en) | Lung-moistening tangerine peel paste and preparation method thereof | |
| CN105902827A (en) | Traditional Chinese medicine composition for improving immunity of human body and preparation method thereof | |
| CN104984296A (en) | Pharmaceutical composition for treating female climacteric syndrome and preparation method thereof | |
| CN105999058B (en) | Bidens bipinnata lipid-lowering tablet | |
| CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN101485823B (en) | Medicament for treating lung cancer and preparation method thereof | |
| CN105250968A (en) | Traditional Chinese medicine preparation for treating asthma | |
| CN106074912B (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases | |
| CN104887950A (en) | Mastitis treatment traditional Chinese medicine compound | |
| CN104306847A (en) | Six-ingredient qi-tonifying capsule and preparation process thereof | |
| CN102166303B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis | |
| CN102139009A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN102379965A (en) | Traditional Chinese medicine for treating chronic prostatitis | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chang Hui Inventor after: Jia Liyan Inventor before: Jia Liyan Inventor before: Chang Hui |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181016 |